Clinical Trials – The Importance of Diversity in Clinical Trials
All the vital news, analysis, and commentary curated by our industry experts.
Clinical trials help us assess the safety and effectiveness of upcoming or existing therapeutics. The clinical trials turn out to be even more successful if the trial participants are representatives of the wider disease population. Lack of diversity in the clinical trial population often minimizes the quality of data obtained for drug safety and efficacy profiles. Furthermore, conducting clinical trials with a diverse demographic set-up ensures a better understanding and a more targeted approach to the administration of therapeutics while providing access to novel groundbreaking therapies in clinical trials.
This diversity in clinical trials market research report provides an analysis of clinical trial racial representation data and evaluates racial demographics across a number of clinical trial sectors to highlight the level of diversity.
Diversity in Clinical Trials – Barriers and Improvement Strategies
For diversity in trials to be improved, factors negatively influencing diversity must be recognized. A major barrier in effectively studying diversity in clinical trials is the low levels of race disclosure of study participants. Increased disclosure would allow for a more accurate assessment of race disparities in the clinical trial landscape.
Strategies to improve diversity across the Pharma industry must be considered where trial populations vastly differ from the disease demographics. Sponsors involved in trials should outline specific targets prior to enrolment to ensure the study population is representative of the disease populations. These targets should be communicated with investigators and primary healthcare providers to reduce the level of implicit bias during recruitment.
For more understanding of strategies to overcome challenges to diversity in clinical trials, download a free sample
Diversity in Clinical Trials Market by Region
The key regions in the clinical trials market are North America, South and Central America, Europe, Middle East and Africa, and Asia-Pacific, among others. North America and South and Central America lead the reporting of race data followed by Europe, Middle East and Africa, and Asia-Pacific, respectively as of July 2022.
Clinical Trials with Disclosed Racial Representation Data, by Region
For more insights on diversity in clinical trials by region, download the free sample
Diversity in Clinical Trials Market by Country
The key countries in the clinical trials market with disclosed racial representation data are Canada, the US, Spain, Germany, France, the UK, Japan, China, India, and Iran among others. Canada had the highest percentage of clinical trials with disclosed racial representation data, followed by the US, Spain, and Germany.
Clinical Trials with Disclosed Racial Representation Data, by Country
For more insights on the diversity in clinical trials by country, download the free sample
Diversity in Clinical Trials Market by Demography
The key demographic groups or study subjects in the clinical trials reporting race data are White, Black or African Americans, Asians, American Indian or Alaska Native, Mixed, and Native Hawaiian or Pacific Islander or Indigenous Australians. Globally, in clinical trials reporting race data, the overwhelming majority of study subjects are white.
Clinical Trials with Disclosed Racial Representation Data, by Demography
For more insights on the diversity in clinical trials by demography, download the free sample
Diversity in Clinical Trials Market by Sponsor Type
The key sponsor types in the clinical trials market are industry sponsors and institutional sponsors. Industry-sponsored trials have a greater proportion of white participants than institutional trials.
Clinical Trials with Disclosed Racial Representation Data, by Sponsor Type
For more information on sponsor types in the clinical trials market, download sample report
Diversity in Clinical Trials Market by Therapy Areas
The key therapy areas in the clinical trials market are Oncology, Central Nervous System Disorders, Infectious Diseases, Cardiovascular, and Metabolic Disorders. Of the top therapy areas, Oncology has the highest representation of Asian participants, with white participants forming the overall majority.
Clinical Trials with Disclosed Racial Representation Data, by Therapy Areas
For more information on therapy types in the clinical trials market, download sample report
Diversity in Clinical Trials Market by Company
Some of the leading companies in the clinical trials market are Novartis, GSK, Pfizer, Johnson & Johnson, AstraZeneca, Eli Lily, F.Hoffmann-La Roche, Merck & Co, AbbVie, and Bayer among others. GSK showcases the most well- rounded diversity where the top three common racial groups are concerned.
Clinical Trials with Disclosed Racial Representation Data, by Company
For more information on diversity in companies in the clinical trials market, download the sample report
Diversity in Clinical Trials Market Overview
|Key Regions||North America, South and Central America, Europe, Middle East and Africa, and Asia-Pacific|
|Key Countries||Canada, the US, Spain, Germany, France, the UK, Japan, China, India, and Iran among others|
|Key Demography||White, Black or African Americans, Asians, American Indian or Alaska Native, Mixed, and Native Hawaiian or Pacific Islander or Indigenous Australians|
|Key Sponsor Type||Industry Sponsors and Institutional Sponsors|
|Key Therapy Areas||Oncology, Central Nervous System, Infectious Diseases, Cardiovascular Diseases, and Metabolic Disorders|
|Key Companies||GSK, Johnson & Johnson, F.Hoffmann – La Roche, AbbVie, and Others|
The clinical trials data used for these analyses was extracted from GlobalData’s Clinical Trials Database, captured on June 16 and July 19, 2022. The data primarily includes clinical trials initiated from January 1, 2013 to June 16, 2022. Disclosed racial representation data has been analyzed by location, by year, phase, therapy area, sponsor type, top industry sponsors, pivotal study status, single country and multinational trials, decentralized trials, and CRO involvement. Additional analysis on obstacles in the recruitment of diverse subject populations in clinical trials and steps which can be taken to increase diversity have also been included.
Reasons to Buy
- Provides a breakdown of racial representation data across a number of clinical trial sectors.
- Identifies which areas are lacking in clinical trial population diversity.
- Highlights the variation in diversity in the industry and against institutional sponsors.
- Documents the barriers to diversity in clinical trials and outlines steps to improve it.
- Assesses how decentralized and virtual components in clinical trials affect diversity.
Johnson & Johnson
F. Hoffmann-La Roche
Merck & Co
Table of Contents
Analysis of Diversity in Clinical Trials (2013–2022)
Frequently asked questions
Which regions lead the reporting of race data in 2022?
North America and South and Central America lead the reporting of race data followed by Europe, Middle East and Africa, and Asia-Pacific, respectively as of July 2022.
Which countries had the highest percentage of clinical trials with disclosed racial representation data in 2022?
Canada had the highest percentage of clinical trials with disclosed racial representation data, followed by the US, Spain, and Germany.
Which race was represented the most in clinical trials market in 2022?
Globally, in clinical trials reporting race data, the overwhelming majority of study subjects are white.
Which are the top companies ensuring diversity in the clinical trials market?
The top companies ensuring diversity in the clinical trials market are GSK, Johnson & Johnson, F.Hoffmann – La Roche, AbbVie, and Others.
What are the different therapy areas covered for diversity in the clinical trials market?
Oncology, Central Nervous System, Infectious Diseases, Cardiovascular Diseases, and Metabolic Disorders are the key therapy areas covered for diversity in the clinical trials market.
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Business Intelligence & Marketing Manager, SAL Heavy Lift
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
Market Analyst & Management, Liebherr-Werk
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Head of Key Accounts, Saab AB
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Marketing Intelligence Manager, Portugal Foods
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Head of Customer Insight and Research, Standard Chartered
Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.
I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.
I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.
Head of Consumer Sensory Insights, Givaudan
“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.
Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”
Senior Account Manager, TSYS
GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.
I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.
One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.